Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening

Prenatal Diagnosis

Volumn 22, Issue 10, 2002, Pages 917-918

  Prefumo, Federico ^a   Thilaganathan, Basky ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Down syndrome; First trimester; Nuchal translucency; Prenatal screening; Validation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DOWN SYNDROME; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST;

ADOLESCENT; ADULT; CHORIONIC VILLI SAMPLING; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; KARYOTYPING; MIDDLE AGED; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 0036796122     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.432     Document Type: Article

References (6)

1. Canick JA, Rish S. 1998. The accuracy of assigned risks in maternal serum screening. Prenat Diagn 18: 413-415.
2. Onda T, Tanaka T, Takeda O, et al. 1998. Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan. Prenat Diagn 18: 956-958.
3. Snijders RJM, Sebire NJ, Nicolaides KH. 1995. Maternal age and gestational-age specific risk for chromosomal defects. Fetal Diagn Ther 10: 356-367.
4. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 351: 343-346.
5. Wald NJ, Huttly WJ. 1999. Validation of risk estimation using the quadruple test in prenatal screening for Down syndrome. Prenat Diagn 19: 1083-1084.
6. Wald NJ, Hackshaw AK, Huttly W, Kennard A. 1996. Empirical validation of risk screening for Down's syndrome. J Med Screen 3: 185-187.